热门资讯> 正文

Edwards Lifesciences推出5亿美元加速股票回购

2025-08-20 04:57

Edwards Lifesciences (NYSE:EW) said on Tuesday that it has signed a $500 million accelerated share repurchase agreement, bringing total buybacks this year to over $800 million.
As per the repurchase agreement, Edwards will receive an initial delivery of about 5 million shares and the remainder at the maturity of the agreement.
Post this offering, co would have around $600 million left under its board-approved repurchase program.
EW +1.53% after hours to $80.14.
Source: Press Release

More on Edwards Lifesciences

Edwards Lifesciences: Gradually Winning My Investment Heart
Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript
Edwards Lifesciences: With A Heart Beating Strong And Steady
FTC sues to block Edwards Lifesciences purchase of JenaValve
Edwards Lifesciences raises 2025 sales growth outlook to 9-10% amid robust TAVR and TMTT momentum

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。